The historical rank and industry rank for Elite Pharmaceuticals's Net Margin % or its related term are showing as below:
ELTP'
s Net Margin % Range Over the Past 10 Years
Min: -122.59 Med: 15.24 Max: 104.11
Current: -8.98
ELTP's Net Margin % is ranked worse than 70.75% of 995
companies
in the Drug Manufacturers industry
Industry Median: 3.96
vs ELTP: -8.98
Elite Pharmaceuticals Net Margin % Historical Data
The historical data trend for Elite Pharmaceuticals's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Elite Pharmaceuticals's Net Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, Elite Pharmaceuticals's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Elite Pharmaceuticals's Net Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Elite Pharmaceuticals's Net Margin % distribution charts can be found below:
* The bar in red indicates where Elite Pharmaceuticals's Net Margin % falls into.
Elite Pharmaceuticals Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Elite Pharmaceuticals's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Elite Pharmaceuticals (OTCPK:ELTP) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Elite Pharmaceuticals Net Margin % Related Terms
Thank you for viewing the detailed overview of Elite Pharmaceuticals's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ELTP has been successfully added to your 